NDC 86184-087-01 - ERTUGLIFLOZIN L-PYROGLUTAMIC ACID
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86184-087
- Requested NDC
- 86184-087-01
- Package NDCs from labels
- 86184-087-01
- Manufacturer
- MAEDA INC
- Effective date
- 2026-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ERTUGLIFLOZIN L-PYROGLUTAMIC ACID - MAEDA INC | MAEDA INC | 2026-06-07 | BULK INGREDIENT - ANIMAL DRUG |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SEGLUROMET | ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | a6aeb99a-ce49-4125-90ce-642df3f1ebad | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | MLU731K321 |
| STEGLATRO | ERTUGLIFLOZIN | Merck Sharp & Dohme LLC | e6f3e718-bb99-48f1-ab94-b9f0af05fed6 | 2026-06-03 | Warnings, Adverse reactions | MLU731K321 |
| STEGLUJAN | ERTUGLIFLOZIN AND SITAGLIPTIN | Merck Sharp & Dohme LLC | c2c553d8-5a9d-4366-bf53-8bdb5a876d19 | 2026-06-03 | Warnings, Adverse reactions | MLU731K321 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.